Letters, Testimony & Comments

Dear Senators Reid and McConnell: On behalf of the more than 430 undersigned organizations representing American innovation from all 50 states and the District of Columbia in fields including agriculture, alternative energy, biotechnology,...
Dear Representative Issa: I write on behalf of the Biotechnology Industry Organization (BIO) to commend your sponsorship of, and express our support for, H.R. 5418, which would establish a pilot program in certain United States district courts...
The Cures Acceleration Network, passed in the recently enacted healthcare reform bill, will provide funding to public and private entities to bridge the gap between basic research and cures for patients.
Part D-Small Business Early-Stage Investment Program Sec. 399A Establishment of Program The Administrator shall establish and carry out an early-stage investment program (hereinafter referred to in this part as the 'program') to...
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the proposed regulations to implement the Biomass Crop Assistance Program (BCAP) enacted by the Food, Conservation, and Energy Act of 2008 (Farm Bill...
BIO provides specific comments and requests clarifications on the text of the Guideline regarding the variability of immunogenicity, approaches for predicting and reducing immunogenicity, clinical consequences of immunogenicity, problems with...
Full Text of the Medicare Modernization Act, Medicare Prescription Drug and Modernization Act of 2003, Public Law 108-173
BIO Testimony Opposing Alaska Senate Bill 25, a bill to label biotech fish and fish products.
Letter to Sonoma County Board of Supervisors outlining BIO’s concerns with the potential implications of the Sonoma County proposed initiative to ban transgenic organisms.
Letter expressing BIO’s concerns with House Bill 2574 (“Certified Rice Act”)
SB 281 propose to require labeling of biotech fish and fish products (Mar. 3, 2004).
Letter to the Honorable John Carey, Chairman of the Senate Committee on Finance and Financial Institutions in Ohio from BIO, regarding House Bill 66.